Page last updated: 2024-08-24

topotecan and belinostat

topotecan has been researched along with belinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chan, JV; Cheok, CF; Chng, WJ; Goh, BC; Hung, HT; Kannan, S; Koh, LYJ; Kong, LR; Lane, DP; Lau, JA; Le, TBU; Lee, M; Lim, CM; Mohamed Salleh, NAB; Ong, RW; Periyasamy, G; Tan, TZ; Thangavelu, M; Venkitaraman, A; Verma, CS; Wang, L	1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1

Other Studies

2 other study(ies) available for topotecan and belinostat

Article	Year
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. Nature communications, 2020, 04-29, Volume: 11, Issue:1 Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cisplatin; Codon; Epigenesis, Genetic; Gain of Function Mutation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Mice, SCID; Models, Biological; Mutant Proteins; Mutation; Neoplasms; NF-kappa B; Nucleotide Motifs; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Isoforms; Sulfonamides; Topotecan; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays	2020
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013

Article

Year

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.

Nature communications, 2020, 04-29, Volume: 11, Issue:1

Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cisplatin; Codon; Epigenesis, Genetic; Gain of Function Mutation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Mice, SCID; Models, Biological; Mutant Proteins; Mutation; Neoplasms; NF-kappa B; Nucleotide Motifs; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Isoforms; Sulfonamides; Topotecan; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2020

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013